In regard to the comment requesting that CMS suspend its requirement to only allow MIPS eligible clinicians, eligible hospitals, and CAHs to spend one performance period in Option 1 (Pre-Production and Validation) before progressing to Option 2 (Validated Data Production), we do not believe that a change to the requirement is necessary given that a significant portion of MIPS eligible clinicians, eligible hospitals, and CAHs attested Yes to Option 1 for the CY 2024 performance period/EHR reporting period in CY 2024 and the Electronic Case Reporting measure is suppressed for the CY 2025 performance period/EHR reporting period in CY 2025, which provides additional time for MIPS eligible clinicians, eligible hospitals, and CAHs to progress from Option 1 (Pre-Production and Validation) to Option 2 (Validated Data Production)
This research compound demonstrates selective NNMT inhibition in cellular metabolism studies, particularly those examining diet-induced obesity and metabolic rate regulation
Peptides work at a cellular level to stimulate hair follicles, improve hair density, and address hair thinning
Answer: There is no strict upper limit, but most protocols build in breaks after 12 to 16 weeks of continuous use to limit tolerance
/product/88/8375914/1.jpg?8254)
